Kidney Week

Oral Abstract Session

AKI Predictors and Outcomes: Research Abstracts

October 23, 2020 | 05:00 PM - 07:00 PM

Location: Simulive

Session Description

Oral Abstract Session

Learning Pathway(s)

• Acute Kidney Injury

Moderator

• Alexander Bullen, MD

Presentations

• Terlipressin Improves Renal Replacement Therapy–Free Survival in Hepatorenal Syndrome Type 1
  05:00 PM - 07:00 PM
  Juan Carlos Q. Velez, MD, FASN 
  
  

  Juan Carlos Q. Velez, MD, FASN

  Dr. Juan Carlos Q. Velez earned a medical degree from Universidad Peruana Cayetano Heredia in Lima, Peru. He completed internship and residency in Internal Medicine at Advocate Illinois Masonic Medical Center in Chicago, where he served as Chief Medical Resident. Subsequently, he completed a clinical and research fellowship in Nephrology at Emory University School of Medicine. Following his training, he joined the Division of Nephrology at the Medical University of South Carolina (MUSC). After spending 11 years of intense clinical, educational and investigational efforts at MUSC, he was recruited by the Department of Nephrology at the Ochsner Clinic Foundation in 2016 to enhance the academic and clinical research programs of the department at the rank of Associate Professor of Medicine at Ochsner Clinical School / The University of Queensland (Brisbane, Australia). He serves as Clerkship Director for Medical Specialties at Ochsner Clinical School. He was appointed as Chair of Nephrology at Ochsner Health System in early 2019. Dr. Velez also holds an appointment as Adjunct Associate Professor of Physiology at Tulane University. Dr. Velez has conducted experimental research in the area of the intrarenal renin-angiotensin system (RAS) that resulted in federal funding and peer-reviewed publications. His work highlighted the role of the angiotensinase aminopeptidase A in glomerular RAS homeostasis. Currently, his areas of expertise and ongoing basic, clinical and translational investigation include hepatorenal syndrome, urinary sediment microscopy, hyponatremia, proteinuric glomerular diseases, kidney ultrasonography, renal syndromes associated with exposure to antimicrobials, and more recently, kidney disease associated with COVID-19. Dr. Velez is certified in Nephrology by the American Board of Internal Medicine, in Kidney Ultrasonography by the American Society of Diagnostic and Interventional Nephrology, and as a Hypertension Specialist by the American Society of Hypertension. He is a selected member of the SSCI. In addition, he served in the American Society of Nephrology (ASN) / National Board of Medical Examiners Fellows In-Training Examination Development Committee. He is a current member of the editorial board of Kidney360 and the ASN COVID-19 Acute Kidney Care Subcommittee.

Terlipressin Improves Renal Replacement Therapy–Free Survival in Hepatorenal Syndrome Type 1

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• A Parsimonious Model for Diagnosis of Biopsy-Proven Acute Interstitial Nephritis Using Electronic Health Record Data
  05:00 PM - 07:00 PM
  Dennis G. Moledina, MD, PhD 
  
  

  Dennis G. Moledina, MD, PhD

  Dr. Moledina is an Assistant Professor of Medicine (Nephrology) at Yale School of Medicine, New Haven, CT. He is board-certified in Nephrology and Internal Medicine. He received his MD from Saurashtra University in India and PhD in Investigative Medicine from Yale University. Dr. Moledina is an NIH-funded clinical and translational researcher focused on improving diagnosis and management of acute kidney injury with specific focus on acute interstitial nephritis.

A Parsimonious Model for Diagnosis of Biopsy-Proven Acute Interstitial Nephritis Using Electronic Health Record Data

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Development and Validation of a Convolutional Neural Network Model for Intensive Care Unit AKI Prediction
  05:00 PM - 07:00 PM
  Jacob Calvert, MS
  
  Jacob Calvert, MS

Development and Validation of a Convolutional Neural Network Model for Intensive Care Unit AKI Prediction

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Outcomes from the Use of the Selective Cytopheretic Device (SCD) in Critically Ill Children Receiving CRRT: A Report of the Multicenter Pediatric SCD (pSCD) Study
  05:00 PM - 07:00 PM
  Stuart Goldstein, MD, FASN 
  
  

  Stuart Goldstein, MD, FASN

  Stuart L Goldstein, MD, is the Clark D West Endowed Chair, Professor of Pediatrics and Director, Center for Acute Care Nephrology at Cincinnati Children’s Hospital Medical Center. He received his medical degree from Columbia University, completed his pediatric residency at Baylor of Medicine in Houston, Texas, and completed both clinical and research fellowships in pediatric nephrology at the Children’s Hospital in Boston, Massachusetts. Dr Goldstein is a member of the American Academy of Pediatrics, the American Society of Nephrology, the International Pediatric Nephrology Association, the American Society of Pediatric Nephrology, the International Society of Nephrology, and the Society for Pediatric Research. He is the Pediatric Nephrologist Representative for the International Society of Nephrology Commission of Acute Renal Failure, and served to the Council of the American Society of Pediatric Nephrology. Dr Goldstein has developed and validated the pediatric modified RIFLE (pRIFLE) AKI criteria, is Founder and Principal Investigator for the Prospective Pediatric AKI Research Group, which conducted the largest multinational prospective AKI study in children, AWARE, results of which have been published in the New England Journal of Medicine. He has evaluated novel urinary AKI biomarkers in the pediatric critical care setting. He was one of two pediatric work group members for the KDIGO International AKI Guideline Work Group and has served on the KDOQI Hemodialysis Adequacy, Vascular Access and Pediatric Nutrition Guideline Work Groups. He has led a multicenter national effort to reduce nephrotoxic AKI in children. He has written over 300 journal articles, served as an Editor for two pediatric nephrology related textbooks and contributed book chapters to numerous texts including, Critical Care Nephrology, Evidence-Based Nephrology, Handbook of Dialysis Therapy, Management of Acute Kidney Problems, Pediatric Critical Care, Pediatric Nephrology, and Pediatric Nephrology in the ICU.

Outcomes from the Use of the Selective Cytopheretic Device (SCD) in Critically Ill Children Receiving CRRT: A Report of the Multicenter Pediatric SCD (pSCD) Study

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Nicotinamide Riboside with Pterostilbene Increases NAD⁺ in Patients with AKI: A Randomized, Double-Blind, Placebo-Controlled, Stepwise Safety Study of NRPT in Patients with AKI
  05:00 PM - 07:00 PM
  Petra Simic, MD, PhD
  
  Petra Simic, MD, PhD

Nicotinamide Riboside with Pterostilbene Increases NAD⁺ in Patients with AKI: A Randomized, Double-Blind, Placebo-Controlled, Stepwise Safety Study of NRPT in Patients with AKI

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Role of Angiopoietins in CKD Progression After Hospitalization
  05:00 PM - 07:00 PM
  Sherry Mansour, MD, MS
  
  Sherry Mansour, MD, MS

Role of Angiopoietins in CKD Progression After Hospitalization

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Determinants of Major Adverse Kidney Events (MAKE) in Extra Corporeal Membrane Oxygenation (ECMO) Survivors
  05:00 PM - 07:00 PM
  Aniesh Bobba, MD 
  
  

  Aniesh Bobba, MD

  I am originally from India. I finished my residency at the cook county hospital, Chicago, and nephrology fellowship at Washington University St.Louis/Barnes Jewish Hospital. I am currently working at the University of Missouri, Columbia. Interested in acute kidney injury, Cardiorenal, and Critical Care nephrology.

Determinants of Major Adverse Kidney Events (MAKE) in Extra Corporeal Membrane Oxygenation (ECMO) Survivors

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• AKI Among African Americans with Sickle Cell Trait and Disease
  05:00 PM - 07:00 PM
  Kabir O. Olaniran, MD, MPH 
  
  

  Kabir O. Olaniran, MD, MPH

  Dr. Olaniran is an Assistant Professor of Medicine at the University of Texas Southwestern Division of Nephrology in Dallas. His research and clinical practice focuses on kidney disorders and cardiovascular outcomes in persons with sickle cell trait and sickle cell disease.

AKI Among African Americans with Sickle Cell Trait and Disease

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Assessment of Kidney Proximal Tubular Secretion in Critical Illness
  05:00 PM - 07:00 PM
  Pavan K. Bhatraju, MD, MS 
  
  

  Pavan K. Bhatraju, MD, MS

  I'm an Assistant Professor in Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine. Our laboratory is interested in understanding the epidemiology and pathophysiology of acute kidney injury in critically ill patients. We also study the identification of predictive biomarkers for acute kidney injury in adults with cystic fibrosis. To accomplish these interests, we are actively enrolling multiple prospective patient cohorts, collecting biological specimens and adjudicating short and long-term clinical outcomes. We use advanced epidemiologic techniques to interpret the association of molecular measurements (genotyping, biomarkers, gene expression) with clinical outcomes.

Assessment of Kidney Proximal Tubular Secretion in Critical Illness

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Endotrophin, Released During Collagen Type VI Formation, Predicts Long-Term Mortality After AKI
  05:00 PM - 07:00 PM
  Nadja Sparding
  
  Nadja Sparding

Endotrophin, Released During Collagen Type VI Formation, Predicts Long-Term Mortality After AKI

October 23, 2020 | 05:00 PM - 07:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.